ASAHI KASEI PHARMA CORPORATION
🇯🇵Japan
Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 270
- Registration Number
- NCT01623622
Collagenase Option for Reduction of Dupuytren's Contracture in Japan
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 104
- Registration Number
- NCT01588353
Clinical Study of AK159 in Healthy Postmenopausal Women
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 132
- Registration Number
- NCT01551602
Study of AK156 in Primary Osteoporosis Patients
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 600
- Registration Number
- NCT01522521
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-01-28
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 240
- Registration Number
- NCT01285752
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Target Recruit Count
- 130
- Registration Number
- NCT00902369
© Copyright 2024. All Rights Reserved by MedPath